Comparison of the efficacy of nifekalant and amiodarone in a porcine model of cardiac arrest

被引:35
作者
Ji, Xian-Fei [1 ]
Li, Chun-Sheng [1 ]
Wang, Shuo [1 ]
Yang, Lin [1 ]
Cong, Lu-Hong [1 ]
机构
[1] Capital Med Univ, Dept Emergency, Beijing Chaoyang Hosp, Beijing 100020, Peoples R China
关键词
Amiodarone; Cardiac arrest; Cardiopulmonary resuscitation; Nifekalant; Ventricular fibrillation; REFRACTORY VENTRICULAR-FIBRILLATION; ACUTE MYOCARDIAL-INFARCTION; III ANTIARRHYTHMIC-DRUG; CARDIOPULMONARY-RESUSCITATION; INTRAVENOUS AMIODARONE; EPINEPHRINE; TACHYARRHYTHMIAS; LIDOCAINE; RECURRENT;
D O I
10.1016/j.resuscitation.2010.04.023
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To compare the efficacy of nifekalant and amiodarone in the treatment of cardiac arrest in a porcine model. Methods: After 4 min of untreated ventricular fibrillation, animals were randomly treated with nifekalant (2 mg kg(-1)), amiodarone (5 mg kg(-1)) or saline placebo (n = 12 pigs per group). Precordial compression and ventilation were initiated after drug administration and defibrillation was attempted 2 min later. Hemodynamics were continuously measured for 6h after successful resuscitation. Results: Compared with saline, nifekalant and amiodarone equally decreased the number of electric shocks, defibrillation energy, epinephrine dose, and duration of cardiopulmonary resuscitation required for successful resuscitation (P <0.01). The incidence of restoration of spontaneous circulation (ROSC) and the 24-h survival rate were higher in both antiarrhythmic drug groups (P < 0.05) vs. the saline group. Furthermore, post-resuscitation myocardial dysfunction at 4-6h after successful resuscitation was improved in animals given antiarrhythmic drugs as compared with the saline group (P< 0.05). There were no differences between nifekalant and amiodarone for any of these parameters. Conclusion: The effect of nifekalant was similar to that of amiodarone for improving defibrillation efficacy and for the treatment of cardiac arrest. Administration of either nifekalant or amiodarone before defibrillation increased the ROSC and 24-h survival rates and improved post-resuscitation cardiac function in this porcine model. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:1031 / 1036
页数:6
相关论文
共 24 条
[1]  
2005 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care, 2005, CIRCULATION, V112
[2]   EFFECTS OF AMIODARONE ON REFRACTORY VENTRICULAR-FIBRILLATION IN ACUTE MYOCARDIAL-INFARCTION - EXPERIMENTAL-STUDY [J].
ANASTASIOUNANA, MI ;
NANAS, JN ;
NANAS, SN ;
RAPTI, A ;
POYADJIS, A ;
STATHAKI, S ;
MOULOPOULOS, SD .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, 23 (01) :253-258
[3]   Atenolol in combination with epinephrine improves the initial outcome of cardiopulmonary resuscitation in a swine model of ventricular fibrillation [J].
Bassiakou, Eleni ;
Xanthos, Theodoros ;
Koudouna, Eleni ;
Goulas, Sotirios ;
Prapa, Vassiliki ;
Papadimitriou, Dimitrios ;
Rokas, George ;
Papadimitriou, Lila .
AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2008, 26 (05) :578-584
[4]   Chest injuries after active compression-decompression cardiopulmonary resuscitation (ACD-CPR) in cadavers [J].
Baubin, M ;
Rabl, W ;
Pfeiffer, KP ;
Benzer, A ;
Gilly, H .
RESUSCITATION, 1999, 43 (01) :9-15
[6]   Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation [J].
Dorian, P ;
Cass, D ;
Schwartz, B ;
Cooper, R ;
Gelaznikas, R ;
Barr, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (12) :884-890
[7]   The resuscitation outcome - Revisit the story of the stony heart [J].
El-Menyar, AA .
CHEST, 2005, 128 (04) :2835-2846
[8]   Defibrillation effects of intravenous nifekalant in patients with out-of-hospital ventricular fibrillation [J].
Igarashi, M ;
Fujino, T ;
Toyoda, M ;
Sugino, K ;
Sasao, K ;
Sasamoto, S ;
Otsuka, T ;
Kobayashi, K ;
Okano, Y ;
Yosiwara, K ;
Koyama, N .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2005, 28 :S155-S157
[9]   Emergency treatment with nifekalant, a novel class III anti-arrhythmic agent, for life-threatening refractory ventricular tachyarrhythmias - Post-marketing special investigation [J].
Katoh, T ;
Mitamura, H ;
Matsuda, N ;
Takano, T ;
Ogawa, S ;
Kasanuki, H .
CIRCULATION JOURNAL, 2005, 69 (10) :1237-1243
[10]  
Katoh T, 1997, J CLIN THER MED, V13, P1659